Empagliflozin mitigates doxorubicin-induced nephrotoxicity by modulating sirtuin 1, nuclear factor-κB/tumor necrosis factor-α, and cleaved caspase-3 pathways without compromising its cytotoxic efficacy

Journal of Pharmacology and Experimental Therapeutics 2026

View at publisher

Authors: Amna G. Tawfik, Heba A. Habib, Esraa M. Zeidan, Gehan H. Heeba

DOI: 10.1016/j.jpet.2026.103817

Cited by: 2

References: 89

Fields of Study & Subjects

Chemotherapy-induced cardiotoxicity and mitigation Chemotherapy-induced organ toxicity mitigation Pancreatic and Hepatic Oncology Research

References 89